Albert Gris-Oliver

Vall dHebron Inst Oncol Expt Therapeut Grp, Barcelona, Spain

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 36 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Table S2 from MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer

Celina García-García,Martín A. Rivas,Yasir H. Ibrahim,María Teresa Calvo,Albert Gris-Oliver,Olga Rodríguez,Judit Grueso,Pilar Antón,Marta Guzmán,Claudia Aura,Paolo Nuciforo,Katti Jessen,Guillem Argilés,Rodrigo Dienstmann,Andrea Bertotti,Livio Trusolino,Judit Matito,Ana Vivancos,Irene Chicote,Héctor G. Palmer,Josep Tabernero,Maurizio Scaltriti,José Baselga,Violeta Serra

crossref（2023）

Cited0Views0Bibtex

Table S1 from Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

Albert Gris-Oliver,Marta Palafox,Laia Monserrat,Fara Brasó-Maristany,Andreu Òdena,Mònica Sánchez-Guixé,Yasir H. Ibrahim,Guillermo Villacampa,Judit Grueso,Mireia Parés,Marta Guzmán,Olga Rodríguez,Alejandra Bruna,Caroline S. Hirst,Alan Barnicle,Elza C. de Bruin,Avinash Reddy,Gaia Schiavon,Joaquín Arribas, Gordon B. Mills,Carlos Caldas,Rodrigo Dienstmann,Aleix Prat,Paolo Nuciforo,Pedram Razavi,Maurizio Scaltriti, Nicholas C. Turner,Cristina Saura, Barry R. Davies,Mafalda Oliveira,Violeta Serra

crossref（2023）

Cited0Views0Bibtex

Table S4 from MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer

crossref（2023）

Cited0Views0Bibtex

Table S3 from MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer

crossref（2023）

Cited0Views0Bibtex

Table S2 from MEK Plus PI3K/mTORC1/2 Therapeutic Efficacy is Impacted by tp53 Mutation in Preclinical Models of Colorectal Cancer

Celina García-García,Martín A. Rivas,Yasir H. Ibrahim,María Teresa Calvo,Albert Gris-Oliver,Olga Rodríguez,Judit Grueso,Pilar Antón,Marta Guzmán,Claudia Aura,Paolo Nuciforo,Katti Jessen,Guillem Argilés,Rodrigo Dienstmann,Andrea Bertotti,Livio Trusolino,Judit Matito,Ana Vivancos,Irene Chicote,Héctor G. Pálmer,Josep Tabernero,Maurizio Scaltriti,José Baselga,Violeta Serra

openalex（2023）

Cited0Views0Bibtex

Figure S1 from Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

Albert Gris-Oliver,Marta Palafox,Laia Monserrat,Fara Brasó-Maristany,Andreu Òdena,Mònica Sánchez-Guixé,Yasir H. Ibrahim,Guillermo Villacampa,Judit Grueso,Mireia Parés,Marta Guzmán,Olga Rodríguez,Alejandra Bruna,Caroline S. Hirst,Alan Barnicle,Elza C. de Bruin,Avinash Reddy,Gaia Schiavon,Joaquín Arribas,Gordon B. Mills,Carlos Caldas,Rodrigo Dienstmann,Aleix Prat,Paolo Nuciforo,Pedram Razavi,Maurizio Scaltriti, Nicholas C. Turner,Cristina Saura, Barry R. Davies,Mafalda Oliveira,Violeta Serra

openalex（2023）

Cited0Views0Bibtex

Table S1 from MEK Plus PI3K/mTORC1/2 Therapeutic Efficacy is Impacted by tp53 Mutation in Preclinical Models of Colorectal Cancer

Celina García-García,Martín A. Rivas,Yasir H. Ibrahim,María Teresa Calvo,Albert Gris-Oliver,Olga Rodríguez,Judit Grueso,Pilar Antón,Marta Guzmán,Claudia Aura,Paolo Nuciforo,Katti Jessen,Guillem Argilés,Rodrigo Dienstmann,Andrea Bertotti,Livio Trusolino,Judit Matito,Ana Vivancos,Irene Chicote,Héctor G. Pálmer,Josep Tabernero,Maurizio Scaltriti,José Baselga,Violeta Serra

openalex（2023）

Cited0Views0Bibtex

Figure S2 from MEK Plus PI3K/mTORC1/2 Therapeutic Efficacy is Impacted by tp53 Mutation in Preclinical Models of Colorectal Cancer

Celina García-García,Martín A. Rivas,Yasir H. Ibrahim,María Teresa Calvo,Albert Gris-Oliver,Olga Rodríguez,Judit Grueso,Pilar Antón,Marta Guzmán,Claudia Aura,Paolo Nuciforo,Katti Jessen,Guillem Argilés,Rodrigo Dienstmann,Andrea Bertotti,Livio Trusolino,Judit Matito,Ana Vivancos,Irene Chicote,Héctor G. Pálmer,Josep Tabernero,Maurizio Scaltriti,José Baselga,Violeta Serra

openalex（2023）

Cited0Views0Bibtex

Figure S5 from Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

crossref（2023）

Cited0Views0Bibtex

Table S2 from Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

crossref（2023）

Cited0Views0Bibtex

Author Statistics

#Papers: 36

#Citation: 933

H-Index: 10

G-Index: 17

Sociability: 6

Diversity: 2

Activity: 23

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn